Sleep Apnea cardioVascular Endpoints (SAVE) trial [ 2011 - 2015 ]

Research Grant

Researchers: Prof R. Douglas Mcevoy (Principal investigator) ,  A/Pr Geraldo Lorenzi ,  Prof Gary Ford ,  Prof Hisatomi Arima ,  Prof Jiguang Wang
View all 7 related researchers

Brief description Obstructive sleep apnea (OSA) affects 7% of the population and is increasing with the global epidemic of obesity. Research suggests that OSA may be a cause of premature cardiovascular (CV) disease, but definitive proof is lacking. This 5-year trial will answer this question by comparing the rate of CV events (eg stroke, heart attack) in OSA patients who are treated, versus those not treated, with CPAP. The results may lead to a new medical approach to the prevention of CV disease.

Funding Amount $AUD 3,160,391.80

Funding Scheme Project Grants

Notes Standard Project Grant